In 2015, sales volume of omeprazole in China was 12.9 tonnes and sales value was RMB one billion, with YoY growth of 5% and 5.2%. In the coming years, with the increase of patients suffered from digestive disease, their need for omeprazole is increasing. Meanwhile, the number of hospitals in the 13th five-year plan period will go up, so is their input of omeprazole. It is predicted that, in 2021, sales value of omeprazole in China will reach RMB1.37 billion.

As the coverage of related policies is expanding, essential medicines with good quality and low price will be the first choice for basic medical institutions. Moreover, people’s medical consciousness increases, insurance institutions lead people to a right direction. The asymmetric phenomenon between consumers and doctors and pharmaceutical enterprises will be improved. There will be more choices of medicines for patients, which will increase sales amount of omeprazole. Under those circumstances, sales of omeprazole tend to grow.

Figure No.	Figure Title
Figure 1	Numbers of China chemical drugs enterprises, 2011-2015
Figure 2	Total assets of China chemical drugs enterprises, 2011-2015
Figure 3	Sales revenues of China chemical drugs industry, 2011-2015
Figure 4	Total profits of China chemical drugs industry, 2011-2015
Figure 5	Asset-liability ratios of China chemical drugs industry, 2011-2015
Figure 6	Rates of profits to cost and expense of China chemical drugs industry, 2011-2015
Figure 7	Rates of income as a percentage of sales of China chemical drugs industry, 2011-2015
Figure 8	Rates of return on total assets of China chemical drugs industry, 2011-2015
Figure 9	Gross profit margins of China chemical drugs industry, 2011-2015
Figure 10	Receivables turnovers of China chemical drugs industry, 2011-2015
Figure 11	Liquidity turnovers of China chemical drugs industry, 2011-2015
Figure 12	Turnovers of total assets of China chemical drugs industry, 2011-2015
Figure 13	Costs of sales of China chemical drugs industry, 2011-2015
Figure 14	Sales expenses of China chemical drugs industry, 2011-2015
Figure 15	Management expenses of China chemical drugs industry, 2011-2015
Figure 16	Financial expenses of China chemical drugs industry, 2011-2015
Figure 17	Output of China chemical drugs industry, 2011-2015
Figure 18	Sales volume of China omeprazole industry, 2011 -2015
Figure 19	Sales value of China omeprazole industry, 2011-2015
Figure 20	Markets shares of key enterprises in China omeprazole industry in 2015
Figure 21	Markets shares of key enterprises in China omeprazole industry in 2015
Figure 22	Sales structure of China omeprazole industry by specifications in 2015
Figure 23	Sales value structure of China omeprazole products of different packages in 2015
Figure 24	Sales volume structure of China omeprazole of different packages in 2015
Figure 25	Sales value structure of China omeprazole products of different packages in 2015
Figure 26	Sales volume of omeprazole in Shanghai, 2011-2015
Figure 27	Sales value of omeprazole in Shanghai, 2011-2015
Figure 28	Sales forecast of omeprazole in Shanghai, 2016-2021
Figure 29	Sales volume of omeprazole in Beijing, 2011-2015
Figure 30	Sales value of omeprazole in Beijing, 2011-2015
Figure 31	Sales forecast of omeprazole in Beijing, 2016-2021
Figure 32	Sales volume of omeprazole in Beijing, 2011-2015
Figure 33	Sales value of omeprazole in Guangzhou, 2011-2015
Figure 34	Sales forecast of omeprazole in Guangzhou, 2016-2021
Figure 35	Sales volume of omeprazole in Zhengzhou, 2011-2015
Figure 36	Sales value of omeprazole in Zhengzhou, 2011-2015
Figure 37	Sales forecast of omeprazole in Zhengzhou, 2016-2021
Figure 38	Sales volume of omeprazole in Hangzhou, 2011-2015
Figure 39	Sales value of omeprazole in Hangzhou, 2011-2015
Figure 40	Sales forecast of omeprazole in Hangzhou, 2016-2021
Figure 41	Sales volume of omeprazole in Tianjin, 2011-2015
Figure 42	Sales value of omeprazole in Tianjin, 2011-2016
Figure 43	Sales forecast of omeprazole in Tianjin, 2016-2021
Figure 44	Sales volume of omeprazole in Jinan, 2011-2015
Figure 45	Sales value of omeprazole in Jinan, 2011-2015
Figure 46	Sales forecast of omeprazole in Jinan, 2016-2021
Figure 47	Sales volume of omeprazole in Chongqing, 2011-2015
Figure 48	Sales value of omeprazole in Chongqing, 2011-2015
Figure 49	Sales forecast of omeprazole in Chongqing, 2016-2021
Figure 50	Sales volume of omeprazole in Chengdu, 2011-2015
Figure 51	Sales value of omeprazole in Chengdu, 2011-2015
Figure 52	Sales forecast of omeprazole in Chengdu, 2016-2021
Figure 53	Sales volume of omeprazole in Nanjing, 2011-2015
Figure 54	Sales value of omeprazole in Nanjing, 2011-2015
Figure 55	Sales forecast of omeprazole in Nanjing, 2016-2021
Figure 56	Sales volume forecast of China omeprazole, 2016-2021
Figure 57	Sales value forecast of China omeprazole, 2016-2021

Table No.	Table Title
Table 1	Economic indicators of China chemical drugs industry, 2013-2015
Table 2	Total assets of China chemical drugs enterprises, 2011-2015
Table 3	Sales revenues of China chemical drugs industry, 2011-2015
Table 4	Total profits of China chemical drugs industry, 2011-2015
Table 5	Costs of sales of China chemical drugs industry, 2011-2015
Table 6	Sales expenses of China chemical drugs industry, 2011-2015
Table 7	Management expenses of China chemical drugs industry, 2011-2015
Table 8	Financial expenses of China chemical drugs industry, 2011-2015
Table 9	omeprazole enterprises in China
Table 10	Sales by regions in China omeprazole industry in 2015
Table 11	Sales volume of omeprazole by specifications in 2015
Table 12	Sales value of omeprazole by specifications in 2015
Table 13	Sales volume of omeprazole of different packages in 2015
Table 14	Sales value of China omeprazole products of different packages in 2015
Table 15	Numbers of hospitals in Shanghai, 2011-2015
Table 16	Numbers of hospitals in Beijing, 2011-2015
Table 17	Numbers of hospitals in Guangzhou, 2011-2015
Table 18	Numbers of hospitals in Zhengzhou, 2011-2015
Table 19	Numbers of hospitals in Hangzhou, 2011-2015
Table 20	Numbers of hospitals in Tianjin, 2011-2015
Table 21	Numbers of hospitals in Jinan, 2011-2015
Table 22	Numbers of hospitals in Chongqing, 2011-2015
Table 23	Numbers of hospitals in Chengdu, 2011-2015
Table 24	Omeprazole products of Jiangsu Aosaikang Pharmaceutical Co., Ltd.
Table 25	Sales revenues and total profits of Jiangsu Aosaikang Pharmaceutical Co., Ltd., 2012-2014
Table 26	Rates of sales profits and gross profits of Jiangsu Aosaikang Pharmaceutical Co., Ltd., 2012-2014
Table 27	Competition advantages of Jiangsu Aosaikang Pharmaceutical Co., Ltd.
Table 28	Omeprazole products of Changzhou Siyao Pharmaceutical Co., Ltd.
Table 29	Sales revenues and total profits of Changzhou Siyao Pharmaceutical Co., Ltd., 2012-2014
Table 30	Sales profit rates and gross profit rates of Changzhou Siyao Pharmaceutical Co., Ltd., 2012-2014
Table 31	Competition advantages of Changzhou Siyao Pharmaceutical Co., Ltd.
Table 32	Development strategy of Changzhou Siyao Pharmaceutical Co., Ltd.
Table 33	Omeprazole products of AstraZeneca
Table 34	Sales revenues and total profits of Wuxi supply base, 2012-2014
Table 35	Sales profit rates and gross profit rates of Wuxi supply base, 2012-2014
Table 36	Competition advantages of AstraZeneca
Table 37	Sales revenues and total profits of Hunan Dinuo Pharmaceutical Co., Ltd., 2012-2014
Table 38	Sales profit rates and gross profit rates of Hunan Dinuo Pharmaceutical Co., Ltd., 2012-2014
Table 39	Omeprazole products of Guilin Hwasun Pharmaceutical Co., Ltd.
Table 40	Sales revenues and total profits of Guilin Hwasun Pharmaceutical Co., Ltd., 2012-2014
Table 41	Sales profit rates and gross profit rates of Guilin Hwasun Pharmaceutical Co., Ltd., 2012-2014
Table 42	Competition advantages of Guilin Hwasun Pharmaceutical Co., Ltd.
Table 43	Omeprazole product of Guizhou Warmen Pharmaceutical Co. Ltd.
Table 44	Sales revenues and total profits of Guizhou Warmen Pharmaceutical Co. Ltd., 2013-2015
Table 45	Competition advantages of Guizhou Warmen Pharmaceutical Co. Ltd.
Table 46	Total assets and total liabilities of Jiangsu Wuzhong Pharmaceutical Group Corporation, 2014-2015
Table 47	Asset-liability ratios and profitability index of Jiangsu Wuzhong Pharmaceutical Group Corporation, 2014-2015
Table 48	Competition advantages of Jiangsu Wuzhong Pharmaceutical Group Corporation
Table 49	Omeprazole products of Jinzhou Jiutai Pharmaceutical
Table 50	Sales revenues and total profits of Jinzhou Jiutai Pharmaceutical, 2012-2014
Table 51	Sales profit rates and gross profit rates of Jinzhou Jiutai Pharmaceutical, 2012-2014
Table 52	Competition advantages of Jinzhou Jiutai Pharmaceutical
Table 53	Revenues and total profits of Guangdong Eashu Pharmaceutical Co., Ltd., 2013-2015
Table 54	Competition advantages of Guangdong Eashu Pharmaceutical Co., Ltd.